- 856245-74-41,2,4-Triazolo[4,3-b]pyridazin-3(2H)-one, 7,8-bis(4-chlorophenyl)-2-[[4-(trifluoromethyl)phenyl]methyl]-
- 856250-49-2Methanesulfonic acid,1,1,1-trifluoro-, 5-chloro-1,6-dihydro-6-oxo-1-(phenylmethyl)-4-pyridazinylester
- 856250-60-7Boronic acid,B-(5-fluoro-6-methoxy-3-pyridinyl)-
- 85625-91-8Calcium,(4-aminobutanoato-N,O)[N-(2,4-dihydroxy-3,3-dimethyl-1-oxobutyl)-b-alaninato]-, [T-4-(R)]- (9CI)
- 85631-66-9Fatty acids, tall-oil,castor-oil alkyl esters
- 85631-82-92,7-Naphthalenedisulfonicacid,5-[2-[2,4-dihydroxy-5-[2-[4-(phenylamino)-3-sulfophenyl]diazenyl]phenyl]diazenyl]-4-hydroxy-3-[2-(4-nitrophenyl)diazenyl]-,sodium salt (1:3)
- 85631-84-11-Naphthalenesulfonicacid,4-[2-[2,4-dihydroxy-5-[2-[3-methyl-4-[2-(2-methyl-5-sulfophenyl)diazenyl]phenyl]diazenyl]phenyl]diazenyl]-,sodium salt (1:2)
- 85631-88-5C.I. Direct Black 168
- 85631-89-62,7-Naphthalenedisulfonicacid,3-[2-(2-chloro-4-nitrophenyl)diazenyl]-4-hydroxy-5-[2-[2-hydroxy-4-[[3-hydroxy-4-[2-[4-[(4-nitro-2-sulfophenyl)amino]phenyl]diazenyl]phenyl]amino]phenyl]diazenyl]-,sodium salt (1:3)
- 85631-95-4Cuprate(3-),[5-(acetylamino)-4-(hydroxy-kO)-3-[2-[2-(hydroxy-kO)-5-methoxy-4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]diazenyl-kN1]-2,7-naphthalenedisulfonato(5-)]-,sodium (1:3)
Hot Products
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
- 7631-86-9Silicon dioxide
- 302-79-4Tretinoin
- 77-92-9Citric acid
|
Basic Information |
|
Post buying leads |
|
Suppliers |
|
Cas Database |
| Name |
Mitozolomide |
EINECS | N/A |
| CAS No. | 85622-95-3 | Density | 1.94g/cm3 |
| PSA | 108.17000 | LogP | -0.67600 |
| Solubility | N/A | Melting Point |
164.5°C |
| Formula | C7H7 Cl N6 O2 | Boiling Point | 555.8°C at 760 mmHg |
| Molecular Weight | 242.625 | Flash Point | 289.9°C |
| Transport Information | N/A | Appearance | N/A |
| Safety | Poison by intraperitoneal route. Human systemic effects by ingestion: nausea or vomiting and blood changes. Experimental reproductive effects. Human mutation data reported. When heated to decomposition it emits toxic fumes of NOx and Cl−. | Risk Codes | N/A |
| Molecular Structure |
|
Hazard Symbols | N/A |
| Synonyms |
8-Carbamoyl-3-(2-chloroethyl)-imidazo[5,1-d]-1,2,3,5-tetrazin-4-one;Azolastone; CCRG 81010; M and B 39565; Mitozolomide; NSC 353451 |
Article Data | 7 |
Mitozolomide Chemical Properties
Molecule structure of Mitozolomide (CAS NO.85622-95-3) :
IUPAC Name: 3-(2-chloroethyl)-4-oxoimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide
Molecular Weight: 242.62248 g/mol
Molecular Formula: C7H7ClN6O2
Density: 1.94 g/cm3
Boiling Point: 555.8 °C at 760 mmHg
Flash Point: 289.9 °C
Index of Refraction: 1.834
Molar Refractivity: 54.99 cm3
Molar Volume: 124.7 cm3
Polarizability: 21.8*10-24 cm3
Surface Tension: 95.5 dyne/cm
Enthalpy of Vaporization: 83.72 kJ/mol
log P (octanol-water): -0.47
Water Solubility: 1190 mg/L
Vapor Pressure: 7.58E-11 mm Hg
Henry's Law Constant: 3.74E-14 atm-m3/mole
Atmospheric OH Rate Constant: 1.68E-11 cm3/molecule-sec
XLogP3: -0.5
H-Bond Donor: 1
H-Bond Acceptor: 5
Rotatable Bond Count: 3
Tautomer Count: 2
Exact Mass: 242.031901
MonoIsotopic Mass: 242.031901
Topological Polar Surface Area: 106
Heavy Atom Count: 16
Complexity: 348
Canonical SMILES: C1=NC(=C2N1C(=O)N(N=N2)CCCl)C(=O)N
InChI: InChI=1S/C7H7ClN6O2/c8-1-2-14-7(16)13-3-10-4(5(9)15)6(13)11-12-14/h3H,1-2H2,(H2,9,15)
InChIKey: QXYYYPFGTSJXNS-UHFFFAOYSA-N
EINECS: 287-943-3
Product Categories: pharmacetical
Mitozolomide History
Development of Mitozolomide (CAS NO.85622-95-3) was discontinued during Phase II clinical trials after it was found to cause severe and unpredictable bone marrow suppression. Temozolomide, which has been in clinical use since 1999, is a less toxic analogue of mitozolomide.
Mitozolomide Toxicity Data With Reference
| 1. | dnd-hmn:emb 50 µmol/L | CNREA8 Cancer Research. 44 (1984),1772. | ||
| 2. | dnd-mus:leu 50 µmol/L | CNREA8 Cancer Research. 44 (1984),1767. | ||
| 3. | orl-hmn TDLo:3108 µg/kg:GIT,BLD | BJCAAI British Journal of Cancer. 55 (1987),433. | ||
| 4. | ipr-mus LD10: 45 mg/kg | BJCAAI British Journal of Cancer. 58 (1988),139. |
Mitozolomide Safety Profile
Poison by intraperitoneal route. Human systemic effects by ingestion: nausea or vomiting and blood changes. Experimental reproductive effects. Human mutation data reported. When heated to decomposition it emits toxic fumes of NOx and Cl−.
Mitozolomide Specification
Mitozolomide (CAS NO.85622-95-3) is also called 3-(2-Chloroethyl)-3,4-dihydro-4-oxoimidazo(5,1-d)-1,2,3,5-tetrazine-8-carboxamide ; 3-(2-Chloroethyl)-3,4-dihydro-4-oxoimidazo(5,1-d)-as-tetrazine-8-carboxamide ; 8-Carbamoyl-3-(2-chloroethyl)imidazo(5,1-d)-1,2,3,5-tetrazin-4(3H)-one ; Azolastone ; BRN 3618072 ; CCRG 81010 ; M & B 39565 ;
Mitozolomida [Spanish] ; Mitozolomidum ; NSC 353451 ; UNII-E3U7286V3W . Mitozolomide (CAS NO.85622-95-3) is an antineoplastic. It is an imidazotetrazine derivative.
What can I do for you?
Get Best Price
